Resistance to cancer chemotherapy: failure in drug response from ADME to P-gp

KO Alfarouk, CM Stock, S Taylor, M Walsh… - Cancer cell …, 2015‏ - Springer
Cancer chemotherapy resistance (MDR) is the innate and/or acquired ability of cancer cells
to evade the effects of chemotherapeutics and is one of the most pressing major dilemmas in …

Recent advances in 2D and 3D in vitro systems using primary hepatocytes, alternative hepatocyte sources and non-parenchymal liver cells and their use in …

P Godoy, NJ Hewitt, U Albrecht, ME Andersen… - Archives of …, 2013‏ - Springer
This review encompasses the most important advances in liver functions and hepatotoxicity
and analyzes which mechanisms can be studied in vitro. In a complex architecture of nested …

Bile acids and FXR: novel targets for liver diseases

M Stofan, GL Guo - Frontiers in medicine, 2020‏ - frontiersin.org
Bile acids (BAs) are evolutionally conserved molecules synthesized in the liver from
cholesterol and have been shown to be essential for lipid homeostasis. BAs regulate a …

[HTML][HTML] Carleman estimates for semi-discrete parabolic operators and application to the controllability of semi-linear semi-discrete parabolic equations

F Boyer, J Le Rousseau - Annales de l'Institut Henri Poincare (C) Non …, 2014‏ - Elsevier
In arbitrary dimension, in the discrete setting of finite-differences we prove a Carleman
estimate for a semi-discrete parabolic operator, in which the large parameter is connected to …

Mechanisms and insights into drug resistance in cancer

H Zahreddine, KLB Borden - Frontiers in pharmacology, 2013‏ - frontiersin.org
Cancer drug resistance continues to be a major impediment in medical oncology. Clinically,
resistance can arise prior to or as a result of cancer therapy. In this review, we discuss …

The molecular basis for the pharmacokinetics and pharmacodynamics of curcumin and its metabolites in relation to cancer

M Heger, RF van Golen, M Broekgaarden… - Pharmacological …, 2014‏ - Elsevier
This review addresses the oncopharmacological properties of curcumin at the molecular
level. First, the interactions between curcumin and its molecular targets are addressed on …

An updated review of pharmacokinetic drug interactions and pharmacogenetics of statins

T Hirota, Y Fujita, I Ieiri - Expert Opinion on Drug Metabolism & …, 2020‏ - Taylor & Francis
Introduction Hydroxymethylglutaryl-coenzyme A reductase inhibitors (statins) lower
cholesterol synthesis in patients with hypercholesterolemia. Increased statin exposure is an …

Multidrug resistance in cancer: role of ATP–dependent transporters

MM Gottesman, T Fojo, SE Bates - Nature reviews cancer, 2002‏ - nature.com
Chemotherapeutics are the most effective treatment for metastatic tumours. However, the
ability of cancer cells to become simultaneously resistant to different drugs—a trait known as …

Peroxisome proliferator‐activated receptor alpha target genes

M Rakhshandehroo, B Knoch, M Müller… - PPAR …, 2010‏ - Wiley Online Library
The peroxisome proliferator‐activated receptor alpha (PPARα) is a ligand‐activated
transcription factor involved in the regulation of a variety of processes, ranging from …

Mammalian drug efflux transporters of the ATP binding cassette (ABC) family: an overview

AH Schinkel, JW Jonker - Advanced drug delivery reviews, 2012‏ - Elsevier
Active drug efflux transporters of the ATP binding cassette (ABC)-containing family of
proteins have a major impact on the pharmacological behavior of most of the drugs in use …